Corporate Update

GenIP PLC

30 June 2026

 

30 June 2026

GenIP Plc

("GenIP" or the "Company")

Corporate Update

GenIP provides a corporate update following the CEO's visit to the UK for the Company's AGM and meetings with clients, investors and strategic partners in June.

The Company hosted a roundtable discussion bringing together innovation leaders from academia, industry and Government, chaired by Lord David Willetts (Chairman of GenIP) and KEUK, to discuss AI's role in improving R&D outcomes.

Management met with investors, brokers and market participants in a series of meetings and lunches where the Company's strategy and growth plans were discussed, and feedback was welcomed from investors.

Strategy sessions with the UK-based team focused on the next phase of growth and development of GenIP's SaaS subscription platform, which remains on track for Q4 2026, targeting 60%+ gross margins and 90-95% automation by early 2027. The platform will formalise repeat purchasing behaviour already demonstrated across the client base and transition GenIP from a services business to a scalable, recurring revenue intelligence platform.

Leveraging GenIP's proprietary database, the platform has also been enhanced by utilising Anthropic's AI technology as part of its AI workflow to further strengthen the quality, speed and depth of its analysis. As GenIP's data flywheel continues to strengthen, with every client engagement enriching its proprietary dataset, the Company is further optimising its offering and reinforcing its position as a leading provider of AI-powered technology intelligence and data-driven decision support.

The CEO also attended the annual Cambridge Dinner hosted by the London Stock Exchange and law firm Bird & Bird, focused on capital markets, venture capital and corporate growth.

The Company continues to build its global partnership network, with the Cardinal IP referral programme now live, generating initial introductions to leading and Fortune 500 corporates and law firms. Partnerships in Latin America with GreenTech (Chile) and Pelotas (Brazil) are driving academic and government pipeline opportunities across the region, while Asia-Pacific and Middle East expansion is underway, including the appointment of an Asia-based sales resource.

Melissa Cruz, CEO of GenIP, commented:

"It was great to be back in London for two weeks spending time with clients, investors and the team. I leave energised by the conversations we've had and with clear direction for the next phase of GenIP's growth. I'm looking forward to sharing more progress in the months ahead."

For further information regarding GenIP, please visit www.genip.ai, or contact:

GenIP Plc Melissa Cruz, CEO		Via Redchurch Communications
AlbR Capital Limited (Joint Broker)  Colin Rowbury Jon Belliss		Tel: [phone] [e-mail]  [e-mail]
CMC Markets (Joint Broker)		Tel: + 44 (0) 203 003 8632
Douglas Crippen
Redchurch Communications (Financial PR) John Casey		[e-mail]

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

Notes to Editors

About GenIP

GenIP is a next-generation business      at the intersection of generative AI and innovation strategy. We empower corporates, venture funds, and research institutions to evaluate, commercialise, and scale breakthrough technologies. By combining proprietary GenAI algorithms with expert human analysis, GenIP delivers decision-grade insights and talent solutions that accelerate innovation outcomes.

Service Offerings

GenIP operates through two synergistic service lines:

Service	Description	Value Proposition
Invention Intelligence Product Suite	AI-powered market intelligence reports assessing the commercial potential of emerging technologies	Enables faster, evidence-based decisions on R&D prioritisation, investment, and IP strategy
IP Commercialization Services	End-to-end engagement to help research organisations commercialise innovations	Provides cost-effective, broad support to achieve our clients' strategic objectives

Together, these services form a unified GenAI-enabled platform for innovation triage and execution.

Vision & Strategy

GenIP aims to become the global leader in generative AI analytics for innovation commercialisation. Our strategy is anchored in three growth pillars:

●     Organic Expansion
Scale Invention Evaluator and Recruitment Services through targeted outreach to corporates, VCs, and research institutions, supported by strategic marketing and digital engagement.

●     Service Deepening
Enhance functionality and margin by expanding GenAI capabilities within both service lines-unlocking new use cases and customer segments.

●     Strategic Acquisitions
Pursue bolt-on acquisitions of complementary GenAI services with validated market traction to broaden our offering and accelerate growth.

Forward looking statements

Certain statements contained in this announcement constitute forward-looking statements. When used in this announcement, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial position, liquidity, prospects, growth, strategies and expectations of the industry in which the Company operates.

Such statements reflect the Company's current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to materially differ from those described in this announcement Should one or more of these risks or uncertainties materialise, or should assumptions underlying forward-looking statements prove incorrect, actual results may differ materially from those described in this announcement as "intended", "planned", "anticipated", "believed", "proposed", "estimated" or "expected".

For the avoidance of doubt, the contents of the Company's website and any hyperlinks accessible from the Company's website are not incorporated by reference into, and do not form part of, this announcement and investors should not rely on them.

-ENDS-

 

END